Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Jatropha dioica may have antiviral, antifungal, and other medicinal properties, but more research is needed.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Baricitinib improved hair loss and arthritis in a lupus patient.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Mollugin may help treat diseases and boost hair growth and anti-aging.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

Baricitinib successfully treated severe hair loss.

Focal palmoplantar callosities may help diagnose non-Herlitz junctional epidermolysis bullosa.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Ziziphus jujube Mill extract can naturally protect corn from fungi.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Baricitinib may effectively treat oral lichen planus.

Overexpression of PTHrP in chondrocytes causes short-limbed dwarfism and delayed bone formation in mice.

A genetic mutation in the LIPH gene causes hair loss and growth defects.

This model can replace animal testing for quick, cost-effective skin toxicity tests.

A specific gene region can control targeted and responsive gene expression in mice, useful for skin disorder treatments.